Regeneron Pharmaceuticals Net Income Per Employee
- Regeneron Pharmaceuticals's annual net income per employee was $292.11 K in fiscal year 2024. The net income per employee decreased $1.84 K from $293.95 K (in 2023) to $292.11 K (in 2024), representing a -0.63% year-over-year decline.
- The Highest net income per employee for Regeneron Pharmaceuticals was $778.87 K in fiscal year 2021.
- The Lowest net income per employee was $147.92 K in fiscal year 2015.
- The Average net income per employee was $321.47 K.
- Net Income per Employee is the amount of profit that a business earns from one employee. Refer to our glossary for more details, examples, and formulas.
Over the past 10 years (2015-2024):
Learn more about Regeneron Pharmaceuticals's Revenue by Segment and Revenue by Region.
Check out competitors to Regeneron Pharmaceuticals in a side-by-side comparison.
Explore additional financial metrics for Regeneron Pharmaceuticals.
Definition of Net Income per Employee :
Regeneron Pharmaceuticals's Net Income Per Employee Trend
| 2014 | 118999.65811966 |
|---|---|
| 2015 | 147920 |
| 2016 | 165837.40740741 |
| 2017 | 193308.22580645 |
| 2018 | 330324.32432432 |
| 2019 | 261209.87654321 |
| 2020 | 385092.62304067 |
| 2021 | 778867.66975309 |
| 2022 | 366078.81191461 |
| 2023 | 293947.95539033 |
| 2024 | 292109.09572355 |
2024
Regeneron Pharmaceuticals's net income per employee was $292.11 K in fiscal year 2024.
2023
Regeneron Pharmaceuticals's net income per employee was $293.95 K in fiscal year 2023.
2022
Regeneron Pharmaceuticals's net income per employee was $366.08 K in fiscal year 2022.
2021
Regeneron Pharmaceuticals's net income per employee was $778.87 K in fiscal year 2021.
2020
Regeneron Pharmaceuticals's net income per employee was $385.09 K in fiscal year 2020.
2019
Regeneron Pharmaceuticals's net income per employee was $261.21 K in fiscal year 2019.
2018
Regeneron Pharmaceuticals's net income per employee was $330.32 K in fiscal year 2018.
2017
Regeneron Pharmaceuticals's net income per employee was $193.31 K in fiscal year 2017.
2016
Regeneron Pharmaceuticals's net income per employee was $165.84 K in fiscal year 2016.
2015
Regeneron Pharmaceuticals's net income per employee was $147.92 K in fiscal year 2015.
Regeneron Pharmaceuticals's Net Income Per Employee (Year-over-Year Change)
| 2015 | 24.3 |
|---|---|
| 2016 | 12.11 |
| 2017 | 16.56 |
| 2018 | 70.88 |
| 2019 | -20.92 |
| 2020 | 47.43 |
| 2021 | 102.25 |
| 2022 | -53 |
| 2023 | -19.7 |
| 2024 | -0.63 |
2024
Regeneron Pharmaceuticals's net income per employee
decreased
-0.63% during fiscal year 2024 compared to
2023.
It represents a decline of
-$1.84 K from
$293.95 K (in
2023) to
$292.11 K (in
2024).
2023
Regeneron Pharmaceuticals's net income per employee
decreased
-19.7% during fiscal year 2023 compared to
2022.
It represents a decline of
-$72.13 K from
$366.08 K (in
2022) to
$293.95 K (in
2023).
2022
Regeneron Pharmaceuticals's net income per employee
decreased
-53% during fiscal year 2022 compared to
2021.
It represents a decline of
-$412.79 K from
$778.87 K (in
2021) to
$366.08 K (in
2022).
2021
Regeneron Pharmaceuticals's net income per employee
increased
102.25% during fiscal year 2021 compared to
2020.
It represents an increase of
$393.78 K from
$385.09 K (in
2020) to
$778.87 K (in
2021).
2020
Regeneron Pharmaceuticals's net income per employee
increased
47.43% during fiscal year 2020 compared to
2019.
It represents an increase of
$123.88 K from
$261.21 K (in
2019) to
$385.09 K (in
2020).
2019
Regeneron Pharmaceuticals's net income per employee
decreased
-20.92% during fiscal year 2019 compared to
2018.
It represents a decline of
-$69.11 K from
$330.32 K (in
2018) to
$261.21 K (in
2019).
2018
Regeneron Pharmaceuticals's net income per employee
increased
70.88% during fiscal year 2018 compared to
2017.
It represents an increase of
$137.02 K from
$193.31 K (in
2017) to
$330.32 K (in
2018).
2017
Regeneron Pharmaceuticals's net income per employee
increased
16.56% during fiscal year 2017 compared to
2016.
It represents an increase of
$27.47 K from
$165.84 K (in
2016) to
$193.31 K (in
2017).
2016
Regeneron Pharmaceuticals's net income per employee
increased
12.11% during fiscal year 2016 compared to
2015.
It represents an increase of
$17.92 K from
$147.92 K (in
2015) to
$165.84 K (in
2016).
2015
Regeneron Pharmaceuticals's net income per employee
increased
24.3% during fiscal year 2015 compared to
-.
It represents an increase of
$28.92 K from
$119.00 K (in
2014) to
$147.92 K (in
2015).
Summary Table
| Period | Net Income per Employee | Year-over-Year Change |
|---|---|---|
| 2024 | $292.11 K | -0.63% |
| 2023 | $293.95 K | -19.7% |
| 2022 | $366.08 K | -53% |
| 2021 | $778.87 K | +102.25% |
| 2020 | $385.09 K | +47.43% |
| 2019 | $261.21 K | -20.92% |
| 2018 | $330.32 K | +70.88% |
| 2017 | $193.31 K | +16.56% |
| 2016 | $165.84 K | +12.11% |
| 2015 | $147.92 K | +24.3% |
